Patients with breast cancer under chemotherapy
Conditions
Interventions
Gold Standard:CK-MB, cTnI, Myo
2D-STI
Sponsors
Department of Ultrasound Imaging, Renmin Hospital of Wuhan University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: The enrolled patients should be female and first diagnosed as breast cancer in pathology after mastectomy and lumpectomy. Before chemotherapy of epirubicin, the patients had undergone imaging tests for the exclusion of distant metastasis. All the patients receive chemotherapy with epirubicin.
Exclusion criteria
Exclusion criteria: Patients had chemotherapy, radiotherapy or endocrinotherapy before the enrollment; patients had heart failure with left ventricular ejection fraction (LVEF) less than 50%; patients with history of other malignant tumors. In addition, patients had also been excluded for lost to follow-up.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| longitudinal strain;circumferential strain;SPE, SEN, ACC, AUC of ROC;SPE, SEN, ACC, AUC of ROC; | — |
Secondary
| Measure | Time frame |
|---|---|
| left ventricular ejection fraction; | — |
Countries
China
Contacts
Public ContactBo Hu
Renmin Hospital of Wuhan University
Outcome results
None listed